Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-06

FDA Approved: NARCAN — Supplemental Application (Emergent Devices Inc.)

View source ↗

Summary

The FDA approved a supplemental application for NARCAN (naloxone hydrochloride nasal spray) submitted by Emergent Devices Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NARCAN (Naloxone hydrochloride nasal)

Snippet

SUPPL AP for NARCAN (NALOXONE HYDROCHLORIDE NASAL)